Bristol-Myers Squibb Co (WBO:BMYS) Days Sales Outstanding : 67.98 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co Days Sales Outstanding?

Bristol-Myers Squibb Co's average Accounts Receivable for the three months ended in Mar. 2024 was €8,132 Mil. Bristol-Myers Squibb Co's Revenue for the three months ended in Mar. 2024 was €10,916 Mil. Hence, Bristol-Myers Squibb Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 67.98.

The historical rank and industry rank for Bristol-Myers Squibb Co's Days Sales Outstanding or its related term are showing as below:

WBO:BMYS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.56 Med: 63.46 Max: 77.57
Current: 67.18

During the past 13 years, Bristol-Myers Squibb Co's highest Days Sales Outstanding was 77.57. The lowest was 43.56. And the median was 63.46.

WBO:BMYS's Days Sales Outstanding is ranked better than
54.35% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.68 vs WBO:BMYS: 67.18

Bristol-Myers Squibb Co's Days Sales Outstanding increased from Mar. 2023 (64.76) to Mar. 2024 (67.98).

Bristol-Myers Squibb Co Days Sales Outstanding Historical Data

The historical data trend for Bristol-Myers Squibb Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Days Sales Outstanding Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

76.81

61.42

57.77

61.80

70.04

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															64.76	65.32	68.28	69.46	67.98

Competitive Comparison of Bristol-Myers Squibb Co's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bristol-Myers Squibb Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Days Sales Outstanding falls into.

Bristol-Myers Squibb Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bristol-Myers Squibb Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (7694.544	+	8144.794)	/	2 )	/	41270.502	*	365
=	7919.669					/	41270.502	*	365
=	70.04

Bristol-Myers Squibb Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (8144.794	+	8119.92)	/	2 )	/	10915.8	*	365 / 4
=	8132.357					/	10915.8	*	365 / 4
=	67.98

Bristol-Myers Squibb Co (WBO:BMYS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Bristol-Myers Squibb Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (WBO:BMYS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (WBO:BMYS) Headlines

No Headlines